Genialis advances biomarker discovery to reduce risk in cancer drug development targeting dna damage response pathways

Boston--(business wire)-- #iso27001--genialis and debiopharm expand collaboration to develop rna-based predictive biomarkers for ddr therapies, advancing precision oncology.

TEM Ratings Summary

TEM Quant Ranking